First Horizon Advisors’s Blueprint Medicines BPMC Stock Holding History

First Horizon Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.69K	Hold	21	–	–	﹤0.01%	1982
2025 Q1	$1.86K	Hold	21	–	–	﹤0.01%	2005
2024 Q4	$1.83K	Buy	21 +6	+40%	+$550	﹤0.01%	2001
2024 Q3	$1.39K	Hold	15	–	–	﹤0.01%	2085
2024 Q2	$1.62K	Hold	15	–	–	﹤0.01%	2032
2024 Q1	$1.42K	Hold	15	–	–	﹤0.01%	2101
2023 Q4	$1.38K	Sell	15 -6	-29%	-$389	﹤0.01%	2125
2023 Q3	$1.05K	Sell	21 -21	-50%	-$1.12K	﹤0.01%	2176
2023 Q2	$2.65K	Buy	42 +16	+62%	+$870	﹤0.01%	1993
2023 Q1	$1.17K	Sell	26 -14	-35%	-$631	﹤0.01%	2221
2022 Q4	$1.75K	Hold	40	–	–	﹤0.01%	2092
2022 Q3	$2K	Sell	40 -23	-37%	-$1.48K	﹤0.01%	1976
2022 Q2	$3K	Buy	63 +37	+142%	+$2.17K	﹤0.01%	1959
2022 Q1	$2K	Sell	26 -109	-81%	-$7.82K	﹤0.01%	1427
2021 Q4	$14K	Sell	135 -14	-9%	-$1.46K	﹤0.01%	1401
2021 Q3	$15K	Buy	149 +99	+198%	+$9.22K	﹤0.01%	1373
2021 Q2	$4K	Buy	50 +37	+285%	+$3.39K	﹤0.01%	1570
2021 Q1	$1K	Buy	+13	New	+$1.3K	﹤0.01%	1752

Other funds holding BPMC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Horizon Advisors's BPMC Position: Q2 2025 in Review

First Horizon Advisors held its Blueprint Medicines (BPMC) position steady in Q2 2025 at 21 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

First Horizon Advisors first reported a position in BPMC in Q1 2021 and has held it in 18 quarters since. The position peaked at $15K in Q3 2021. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

First Horizon Advisors held 21 shares of Blueprint Medicines worth $2.69K as of Q2 2025.
First Horizon Advisors left its Blueprint Medicines share count unchanged in Q2 2025.
Blueprint Medicines made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1982 holding.
First Horizon Advisors first reported a position in Blueprint Medicines in Q1 2021 and has held it in 18 quarters since.
First Horizon Advisors's Blueprint Medicines position peaked at $15K in Q3 2021.
354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.